Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 13Gastrointestinal 7Thoracic 6Other hematologic neoplasm 3Myeloid 3Sarcoma 2Lymphoid 2Breast 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Prostatic Neoplasms 1214Urinary Bladder Neoplasms 386Carcinoma, Renal Cell 329Kidney Neoplasms 205Neoplasms 157Breast Neoplasms 146Lung Neoplasms 101Carcinoma, Transitional Cell 99Colorectal Neoplasms 77Testicular Neoplasms 74Ovarian Neoplasms 62Melanoma 60Pancreatic Neoplasms 57Colonic Neoplasms 50Carcinoma, Non-Small-Cell Lung 50Head and Neck Neoplasms 47Stomach Neoplasms 45Non-Muscle Invasive Bladder Neoplasms 45Disease 45Neoplasm Metastasis 41Liver Neoplasms 40Uterine Cervical Neoplasms 39Esophageal Neoplasms 37Wilms Tumor 36Prostatic Hyperplasia 36Adenocarcinoma 33Multiple Myeloma 32Urologic Neoplasms 30Sarcoma 30Recurrence 30

Interventions

Surgical Procedures, Operative 1Radiotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms, Second Primary × Genitourinary × Clear all
NCT06531629 2024-08-06

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

Peking University First Hospital

Completed
72,408 enrolled
Genitourinary

Kidney Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡